Gao G et al. |
Rapamycin inhibits hydrogen peroxide-induced loss of vascular contractility. |
2011 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:21357511
|
Giordano A et al. |
Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells. |
2012 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:22058159
|
Fauconnier J et al. |
Frequency-dependent and proarrhythmogenic effects of FK-506 in rat ventricular cells. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15471978
|
Balasubramaniam R et al. |
Caffeine-induced arrhythmias in murine hearts parallel changes in cellular Ca(2+) homeostasis. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15923307
|
Hafizi S et al. |
ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. |
2004 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15317677
|
Sasamori K et al. |
Cyclic ADP-ribose, a putative Ca2+-mobilizing second messenger, operates in submucosal gland acinar cells. |
2004 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:14990397
|
Lum H et al. |
Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction. |
2001 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:11504680
|
Yaghi A and Sims SM |
Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle. |
2005 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:16055480
|
Bouvier N et al. |
Cyclosporine triggers endoplasmic reticulum stress in endothelial cells: a role for endothelial phenotypic changes and death. |
2009 |
Am. J. Physiol. Renal Physiol. |
pmid:18987109
|
Ren H et al. |
Phosphatase inhibition increases AQP2 accumulation in the rat IMCD apical plasma membrane. |
2016 |
Am. J. Physiol. Renal Physiol. |
pmid:27488997
|
Thai TL et al. |
ADP-ribosyl cyclase and ryanodine receptor activity contribute to basal renal vasomotor tone and agonist-induced renal vasoconstriction in vivo. |
2007 |
Am. J. Physiol. Renal Physiol. |
pmid:17652368
|
Peherstorfer E et al. |
Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells. |
2002 |
Am. J. Physiol. Renal Physiol. |
pmid:12060601
|
Axelsson J et al. |
Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability. |
2013 |
Am. J. Physiol. Renal Physiol. |
pmid:23657856
|
Mohebbi N et al. |
The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins. |
2009 |
Am. J. Physiol. Renal Physiol. |
pmid:19439519
|
Cho SG et al. |
Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis. |
2010 |
Am. J. Physiol. Renal Physiol. |
pmid:20410216
|
De Miguel C et al. |
Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. |
2011 |
Am. J. Physiol. Renal Physiol. |
pmid:21159736
|
Rojas-Vega L et al. |
Increased phosphorylation of the renal Na+-Cl- cotransporter in male kidney transplant recipient patients with hypertension: a prospective cohort. |
2015 |
Am. J. Physiol. Renal Physiol. |
pmid:26336164
|
Edinger RS et al. |
Effect of immunosuppressive agents on glucocorticoid receptor function in A6 cells. |
2002 |
Am. J. Physiol. Renal Physiol. |
pmid:12110508
|
Ilori TO et al. |
Acute calcineurin inhibition with tacrolimus increases phosphorylated UT-A1. |
2012 |
Am. J. Physiol. Renal Physiol. |
pmid:22205230
|
Amberg GC et al. |
Regulation of A-type potassium channels in murine colonic myocytes by phosphatase activity. |
2001 |
Am. J. Physiol., Cell Physiol. |
pmid:11698261
|
Ahn HS et al. |
Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property. |
2007 |
Am. J. Physiol., Cell Physiol. |
pmid:17166943
|
Wang YX et al. |
FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. |
2004 |
Am. J. Physiol., Cell Physiol. |
pmid:14592808
|
Sans MD and Williams JA |
Calcineurin is required for translational control of protein synthesis in rat pancreatic acini. |
2004 |
Am. J. Physiol., Cell Physiol. |
pmid:15044154
|
Bayguinov O et al. |
Muscarinic stimulation increases basal Ca(2+) and inhibits spontaneous Ca(2+) transients in murine colonic myocytes. |
2001 |
Am. J. Physiol., Cell Physiol. |
pmid:11171588
|
Angus LM et al. |
Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1{alpha}, drives utrophin gene expression at the neuromuscular junction. |
2005 |
Am. J. Physiol., Cell Physiol. |
pmid:15930144
|
Zhang Y et al. |
K restriction inhibits protein phosphatase 2B (PP2B) and suppression of PP2B decreases ROMK channel activity in the CCD. |
2008 |
Am. J. Physiol., Cell Physiol. |
pmid:18184875
|
Yue G et al. |
The effect of rapamycin on single ENaC channel activity and phosphorylation in A6 cells. |
2000 |
Am. J. Physiol., Cell Physiol. |
pmid:10898719
|
Nam JH et al. |
Expression of TASK-2 and its upregulation by B cell receptor stimulation in WEHI-231 mouse immature B cells. |
2011 |
Am. J. Physiol., Cell Physiol. |
pmid:21307343
|
Nakagawa K et al. |
Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. |
2015 |
Am. J. Reprod. Immunol. |
pmid:25394810
|
Nakagawa K et al. |
Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures. |
2017 |
Am. J. Reprod. Immunol. |
pmid:28466977
|
Saito S et al. |
Role of Paternal Antigen-Specific Treg Cells in Successful Implantation. |
2016 |
Am. J. Reprod. Immunol. |
pmid:26706630
|
Kofod L et al. |
Endometrial immune markers are potential predictors of normal fertility and pregnancy after in vitro fertilization. |
2017 |
Am. J. Reprod. Immunol. |
pmid:28440588
|
Tabata C et al. |
Calcineurin/NFAT pathway: a novel regulator of parturition. |
2009 |
Am. J. Reprod. Immunol. |
pmid:19527231
|
Goldthorpe H et al. |
Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis transgenic mice. |
2015 |
Am. J. Respir. Cell Mol. Biol. |
pmid:25879383
|
Fujiki M et al. |
Role of T cells in bronchoalveolar space in the development of interstitial pneumonia induced by superantigen in autoimmune-prone mice. |
1999 |
Am. J. Respir. Cell Mol. Biol. |
pmid:10572064
|
Deuse T et al. |
Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation. |
2010 |
Am. J. Respir. Cell Mol. Biol. |
pmid:19880819
|
Rolfe FG et al. |
Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription. |
1997 |
Am. J. Respir. Cell Mol. Biol. |
pmid:9271313
|
Yerkovich ST et al. |
Survival after bronchiolitis obliterans syndrome. |
2011 |
Am. J. Respir. Crit. Care Med. |
pmid:21325085
|
Bhorade S et al. |
Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. |
2011 |
Am. J. Respir. Crit. Care Med. |
pmid:20833822
|
Koshika T et al. |
Pretreatment with FK506 improves survival rate and gas exchange in canine model of acute lung injury. |
2001 |
Am. J. Respir. Crit. Care Med. |
pmid:11208629
|
Saeki K et al. |
Endobronchial Lesions of Mycobacterium abscessus Infection in an Immunocompromised Patient. |
2017 |
Am. J. Respir. Crit. Care Med. |
pmid:28199133
|
Joshi MS et al. |
Calcineurin regulates myocardial function during acute endotoxemia. |
2006 |
Am. J. Respir. Crit. Care Med. |
pmid:16424445
|
Fauvel H et al. |
Protective effects of cyclosporin A from endotoxin-induced myocardial dysfunction and apoptosis in rats. |
2002 |
Am. J. Respir. Crit. Care Med. |
pmid:11850335
|
Spiekerkoetter E et al. |
Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. |
2015 |
Am. J. Respir. Crit. Care Med. |
pmid:26177174
|
Raofi V et al. |
A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants. |
1999 |
Am. J. Surg. |
pmid:10326847
|
Tanaka K et al. |
Living related liver transplantation in children. |
1994 |
Am. J. Surg. |
pmid:7517649
|
Li X et al. |
Increased iNOS-expressing macrophage in long-term surviving rat small-bowel grafts. |
2007 |
Am. J. Surg. |
pmid:17618815
|
Rabkin JM et al. |
Immunosuppression impact on long-term cardiovascular complications after liver transplantation. |
2002 |
Am. J. Surg. |
pmid:12034401
|
Jurim O et al. |
Living-donor liver transplantation at UCLA. |
1995 |
Am. J. Surg. |
pmid:7538267
|
Lee KK et al. |
Successful treatment of ongoing intestinal allograft rejection permits recovery of graft structure and function. |
1993 |
Am. J. Surg. |
pmid:7678188
|
Finn L et al. |
Epstein-Barr virus infections in children after transplantation of the small intestine. |
1998 |
Am. J. Surg. Pathol. |
pmid:9500771
|
Randhawa PS et al. |
The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. |
1993 |
Am. J. Surg. Pathol. |
pmid:7680544
|
Minervini MI et al. |
Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). |
2000 |
Am. J. Surg. Pathol. |
pmid:10757402
|
Randhawa PS et al. |
Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy. |
1996 |
Am. J. Surg. Pathol. |
pmid:8772784
|
Frassetto LA et al. |
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17949460
|
Singh K et al. |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. |
2014 |
Am. J. Transplant. |
pmid:25359003
|
Tang Q |
Pharmacokinetics of therapeutic Tregs. |
2014 |
Am. J. Transplant. |
pmid:25358900
|
Wen X et al. |
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27137884
|
Sikma MA et al. |
Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. |
2015 |
Am. J. Transplant. |
pmid:26053114
|
de Fontbrune FS et al. |
Veno-occlusive disease of the liver after lung transplantation. |
2007 |
Am. J. Transplant. |
pmid:17697264
|
Abdelmalek MF et al. |
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. |
2012 |
Am. J. Transplant. |
pmid:22233522
|
Gupta G et al. |
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. |
2015 |
Am. J. Transplant. |
pmid:25988397
|
Ekberg H et al. |
Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. |
2009 |
Am. J. Transplant. |
pmid:19563339
|
Suszynski TM et al. |
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
2013 |
Am. J. Transplant. |
pmid:23432755
|
Damon C et al. |
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening. |
2017 |
Am. J. Transplant. |
pmid:27597269
|
Shuker N et al. |
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation. |
2016 |
Am. J. Transplant. |
pmid:26714287
|
Flechner SM et al. |
Allotransplantation of cryopreserved parathyroid tissue for severe hypocalcemia in a renal transplant recipient. |
2010 |
Am. J. Transplant. |
pmid:20883540
|
BenÃtez CE et al. |
ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20883560
|
Böger CA et al. |
Reverse diastolic intrarenal flow due to calcineurin inhibitor (CNI) toxicity. |
2006 |
Am. J. Transplant. |
pmid:16889550
|
Tan HP et al. |
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. |
2006 |
Am. J. Transplant. |
pmid:16889606
|
Arnold R et al. |
Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:23841745
|
Pescovitz MD et al. |
A randomized, double-blind, pharmacokinetic study of oral maribavir with tacrolimus in stable renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19663892
|
Gao R et al. |
Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells. |
2007 |
Am. J. Transplant. |
pmid:17391142
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Neuberger JM et al. |
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. |
2009 |
Am. J. Transplant. |
pmid:19120077
|
Momper JD et al. |
The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. |
2011 |
Am. J. Transplant. |
pmid:21714845
|
Tan HP et al. |
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. |
2009 |
Am. J. Transplant. |
pmid:19120078
|
Lemahieu WP et al. |
CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. |
2004 |
Am. J. Transplant. |
pmid:15307840
|
De Simone P et al. |
Everolimus with reduced tacrolimus in liver transplantation. |
2013 |
Am. J. Transplant. |
pmid:23601137
|
Luther P and Baldwin D |
Pioglitazone in the management of diabetes mellitus after transplantation. |
2004 |
Am. J. Transplant. |
pmid:15575920
|
Cherukuri A et al. |
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. |
2012 |
Am. J. Transplant. |
pmid:22390816
|
Pascher A et al. |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. |
2015 |
Am. J. Transplant. |
pmid:25677074
|
Chen G et al. |
A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys. |
2006 |
Am. J. Transplant. |
pmid:16539628
|
Mulay AV et al. |
Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. |
2009 |
Am. J. Transplant. |
pmid:19353768
|
Bahra M et al. |
MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course. |
2005 |
Am. J. Transplant. |
pmid:15644002
|
Montgomery SP et al. |
Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. |
2002 |
Am. J. Transplant. |
pmid:12118862
|
Ahsan N et al. |
Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation. |
2002 |
Am. J. Transplant. |
pmid:12118902
|
van Hooff JP et al. |
Glucose metabolic disorder after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17511670
|
Silva HT et al. |
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17217442
|
Tedesco-Silva H et al. |
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. |
2015 |
Am. J. Transplant. |
pmid:25988935
|
Pech T et al. |
Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. |
2012 |
Am. J. Transplant. |
pmid:22974463
|
Kaplan B and Kirk AD |
Tacrolimus and sirolimus: when bad things happen to good drugs. |
2006 |
Am. J. Transplant. |
pmid:16827845
|
McAlister VC et al. |
Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. |
2006 |
Am. J. Transplant. |
pmid:16827858
|
Gallon L et al. |
Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. |
2006 |
Am. J. Transplant. |
pmid:16827862
|
Grenda R et al. |
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16827869
|
Vanhove T et al. |
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients. |
2016 |
Am. J. Transplant. |
pmid:27013142
|
Posselt AM et al. |
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. |
2010 |
Am. J. Transplant. |
pmid:20659093
|
Echeverri GJ et al. |
Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. |
2009 |
Am. J. Transplant. |
pmid:19775318
|
Gaston RS et al. |
Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. |
2009 |
Am. J. Transplant. |
pmid:19459794
|
Brennan DC et al. |
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. |
2005 |
Am. J. Transplant. |
pmid:15707414
|